|
Volumn 14, Issue 1, 2001, Pages 12-31
|
The year's new drugs
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
22 OXACALCITRIOL;
ALMOGRAM;
ALMOTRIPTAN;
ALOSETRON;
AZULETIL;
BETOTASTINE;
BOTULINUM TOXIN B;
BUDESONIDE;
BUDESONIDE PLUS FORMOTEROL;
DEXMEDETOMIDINE;
DOFETILIDE;
DOSMALFATE;
ESOMEPRAZOLE;
ETIRACETAM;
FORMOTEROL;
FROVATRIPTAN;
GLIBENCLAMIDE PLUS METFORMIN;
HUMAN GROWTH HORMONE;
INSULIN GLARGINE;
LAFUTIDINE;
LEVOBUPIVACAINE;
LEVODOPA METHYL ESTER;
LEVOSIMENDAN;
METFORMIN;
METHYLPHENIDATE;
MITOXANTRONE;
MORPHINE SULFATE;
NITRIC OXIDE;
OROS;
PEROSPIRONE;
POLYCARBOPHIL CALCIUM;
RAMATROBAN;
RAMIPRIL;
RECOMBINANT ALPHA2B INTERFERON;
TALTIRELIN;
TELMISARTAN;
TENECTEPLASE;
UNCLASSIFIED DRUG;
ZIPRASIDONE;
ZOFENOPRIL;
ALLERGIC RHINITIS;
ASTHMA;
ATTENTION DEFICIT DISORDER;
CARDIOVASCULAR DISEASE;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG MARKETING;
DRUG SAFETY;
DYSTONIA;
EPILEPSY;
EXTRAPYRAMIDAL SYMPTOM;
GASTROESOPHAGEAL REFLUX;
HEART ATRIUM FIBRILLATION;
HEART FAILURE;
HEART INFARCTION;
HUMAN;
MIGRAINE;
MULTIPLE SCLEROSIS;
PAIN;
PARKINSON DISEASE;
REVIEW;
SCHIZOPHRENIA;
SEXUAL DYSFUNCTION;
SPINOCEREBELLAR DEGENERATION;
WEIGHT GAIN;
|
EID: 0035024905
PISSN: 02140934
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (23)
|
References (0)
|